Share

CLINICAL TRIAL SEARCH RESULTS

NEW SEARCH
 Number: HOG QL12-153 Principal Investigator: Picus, Joel
Title: Phase II study of Fosaprepitant + 5HT3 receptor antagonists + Dexamethasone in patients with germ cell tumors undergoing 5 day Cisplatin based chemotherapy
Description: The purpose of this study is to determine if EMEND can reduce sudden and delayed symptoms of nausea and vomiting in patients with germ cell cancer that are receiving standard treatment with a 5-day Cisplatin-based chemotherapy....MORE
___________________________________________________________________________________________________
 Number: 201108327 Principal Investigator: Wang-Gillam, Andrea
Title: Phase I Study of Erlotinib and Temsirolimus in Resistant Solid Malignancies
Description: The purpose of this study is to determine the maximum tolerated dose and side effects of the combination of two drugs, temsirolimus and erlotinib, used to treat solid tumor cancers. Temsirolimus is approved by the Food and Drug Administration (FDA) for treatment of renal cancer and is considered inv...MORE
___________________________________________________________________________________________________
 Number: 201107068 Principal Investigator: Lockhart, A. Craig
Title: Phase I Safety and Pharmacokinetic Study of XRP6258 (Cabazitaxel) In Advanced Solid Tumor Patients with Varying Degrees of Hepatic Impairment
Description: The purpose of this study is to determine if Cabazitaxel is a safe treatment for patients with advanced cancers of different types who also have different levels of liver dysfunction. The highest safe dose of cabazitaxel (the maximum tolerated dose, or MTD) that can be given to patients with your le...MORE
___________________________________________________________________________________________________